Black Kestral Group is a US & UK Healthcare & Lifescience Focused Investment & Advisory Firm doing Pre-seed to Pre-IPO investments. Their investment mandate holds a 50-50 blend of binary and non-binary therapeutic investments targeting companies both pre-revenue and those with consistent cash flow. They also represent a handful of family offices globally looking for access to fast growing startups across fintech, financial services, big data, consumer, ecommerce, and digital platforms, doing 5-100M Cheque sizes with a particular interest in US & SEA companies; stage agnostic. **Black Sparrow Group Pte. Ltd. ("Black Kestral Group") ("The Company") is registered in Singapore (UEN 201920242N) and has its registered office at Workcentral, Singapore, 239924. Black Kestral Group is fully compliant to Monetary Authority of Singapore’s (MAS) Standards and works as a member/client under Xen Capital Pte. Ltd., whose Capital Market Services (CMS) License Number is 100638-1, and in Hong Kong also works under Xen Capital, SFC (Type 6), CE BNX995. The company has an internal US Representative who is fully licensed and qualified to deal in Securities in the USA, whose license is housed under a FINRA Registered Broker-Dealer.